Refer a patient for screening and trials
Dementia trials are slow and expensive compared to other disease conditions. Despite the high number of persons developing Alzheimer’s disease each year, on average a clinical trial site only recruits 8-10 participants per year for a particular trial. Among those referred to a trial, most fail the strict inclusion/exclusion criteria.
Access free diagnostic assessment for your patient
By referring your patient to the Australian Dementia Network Screening and Trials program, your patient will undergo a comprehensive free diagnostic assessment using techniques that are not routinely available, such as PET amyloid and tau brain scans. With these methods, Alzheimer’s disease can be detected up to 15 years before symptoms become evident (“preclinical AD”).
Results from the assessments are provided to the referring doctor, along with tailored trial recommendations.
We currently have screening sites operating in Melbourne, Adelaide, Sydney, Newcastle, Brisbane and Perth.
If you have general queries about ADNeT Screening, please contact Dr Jo Robertson – Australian Dementia Network Screening and Trials Coordinator or complete our contact form. You can refer your patient by completing the electronic form below, or download a copy of your local referral form.
Refer a patient now
- Probable MCI or mild AD
- Fluent in English
- Aged ≥ 50 years
- MMSE score ≥ 20
- Reliable study partner/informant available
- Able to tolerate neuropsychological assessment
- Formal education of ≥7 years
- No serious unstable comorbid conditions